Tel. +49 203 / 555858-31,-32,-33 · Fax: +49 203 / 35 82 99
08.08.2018
Genekam is working on potential therapeutic molecules and antibodies against pandemic influenza viruses
13.06.2018
3D Genomemedicine Inc is going to operate in USA
Genekam is to take part in European Community FP7 funded and approved research project called STRUCTGEL to develop nanomedicine applications in Stemcell field.